Bio-Rad Laboratories | BIO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 5.7B 1.09B 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Merck USD 14.57B 3.6B 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Pacific Biosciences Of California USD 279.51M 223.04M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 14.5B 146M 2025-09
Standard Biotools USD 118.21M 11.2M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tosoh JPY 133.1B 10.44B 2025-09
Waters USD 587.83M 128.71M 2025-12